Navigation Links
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
Date:2/12/2008

18 months as CEO, I have been deeply impressed by the commitment and dedication of our employees to our mission and goals, and the strong belief they share with me in the promise of Bristol-Myers Squibb as a BioPharma leader for the future. We're now embarking together on an exciting transformation aimed at making this company better able to deliver superior value to shareholders while also helping more people prevail over serious disease.

"I'm also honored to be succeeding Jim Robinson as chairman. Jim's long and distinguished tenure on our Board has been characterized by many successes and achievements. He came to the chairmanship during a challenging period in our company's recent past, moving quickly to restore confidence, build trust and inspire belief in the importance of our mission and the tremendous opportunities ahead. He has been a trusted advisor and a friend, and I'm grateful for the confidence he has shown in me and in our management team as we move forward."

Prior to coming to Bristol-Myers Squibb, Mr. Cornelius served as chairman emeritus of the Guidant Board of Directors upon closing of its merger into Boston Scientific in April 2006. Previously he had been chairman and CEO during the merger process and was responsible for the company's initial public offering and subsequent split-off from Eli Lilly and Company in 1995.

Mr. Cornelius was a member of the Board of Directors of Eli Lilly, a member of its Executive Committee and chief financial officer from 1983 to 1995. From 1980 to 1982, he served as president and CEO of IVAC Corporation, previously an Eli Lilly subsidiary. He was born in Kalamazoo, Michigan, and attended Michigan State University, where he earned a BA magna cum laude in accounting in 1965 and an MBA in 1967.

Bristol-Myers Squibb Company is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
3. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
7. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
8. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. KGI Elects Three New Members to Board of Trustees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... 2015 The Pittcon 2015 Exposition, ... Ernest N. Morial Convention Center in New Orleans, ... February 19, 2015) displaying products and services used ... government labs. The Exposition will offer the latest ... to, analytical chemistry; drug discovery; nanotechnology; life sciences ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Favrille, Inc. (Nasdaq:,FVRL) today announced that it ... 2008 indicating that, for the last 30 consecutive ... common stock has been below,the minimum $1.00 per ... $5,000,000 minimum market value of publicly held shares ...
... the ... Treatment of Stuttering, ROANOKE, Va., ... non-profit research and,clinical center ( http://www.stuttering.org ) specializing ... stuttering,therapy with advanced behavioral, electronic and computer technologies that,significantly improve ...
... for Aging Services Technologies, (CAST) to Expedite Emerging ... 15 Samarion CEO Mark Rodgers was,recently named ... to help lead the charge to expedite emerging ... an international coalition ensuring that technology solutions,attain their ...
Cached Biology Technology:Favrille Announces Receipt of Nasdaq Letters 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 3Samarion CEO Mark Rodgers Named CAST Commissioner 2
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... HAIFA, Israel , April 27, 2010 Oil Refineries,Ltd. (TASE: ... its Annual & Special General,Meeting scheduled for Monday, April 26, 2010 to Monday, ... remains the same. , , , ... , , ...
... , April 27, 2010 Cellcom Israel,Ltd. (NYSE: ... of a purported,class action lawsuit filed in March 2009 ... by a plaintiff alleging to be the Company,s,subscriber, in connection ... The purported class action was dismissed,without prejudice, following the request ...
... Tuesday morning between Temple University Hospital (TUH) and the Pennsylvania Association of ... resume later today at 1:00 p.m. , ... Continued progress was reported, but the parties remain apart on economics. , ... Temple University Hospital is committed to meet with the ...
Cached Biology News:Oil Refineries Announces Delay to Annual & Special General Meeting 2Cellcom Israel Ltd. Announces Dismissal of a Purported Class Action 2
... 2-3x faster than western blotting. Get results ... Direct on gel detection. Eliminates the need ... detection methods. All reagents are ready-to-use. No ... to use. Only 2 reagents required. Guarantees a ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
... This kit is designed to knockout or alter ... less than one week. Red/ET recombination allows the ... precise, specific, and faithful manner. An FRT-flanked kanamycin ... which can be used to replace a gene ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: